Exscientia PLC EXAI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
4.70quote price arrow up+0.03 (+0.64%)
Volume
36,236
Close
4.67quote price arrow down-0.42 (-8.25%)
Volume
594,508
52 week range
3.86 - 9.12
Loading...
  • Open5.21
  • Day High5.24
  • Day Low4.67
  • Prev Close5.09
  • 52 Week High9.12
  • 52 Week High Date08/01/23
  • 52 Week Low3.86
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap588.979M
  • Shares Out126.12M
  • 10 Day Average Volume0.48M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change-27.15

KEY STATS

  • Open5.21
  • Day High5.24
  • Day Low4.67
  • Prev Close5.09
  • 52 Week High9.12
  • 52 Week High Date08/01/23
  • 52 Week Low3.86
  • 52 Week Low Date04/25/24
  • Market Cap588.979M
  • Shares Out126.12M
  • 10 Day Average Volume0.48M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change-27.15

RATIOS/PROFITABILITY

  • EPS (TTM)-1.48
  • P/E (TTM)-3.16
  • Fwd P/E (NTM)-3.99
  • EBITDA (TTM)-197.473M
  • ROE (TTM)-34.98%
  • Revenue (TTM)25.161M
  • Gross Margin (TTM)-36.47%
  • Net Margin (TTM)-726.94%
  • Debt To Equity (MRQ)5.32%

EVENTS

  • Earnings Date05/20/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Exscientia PLC

 

Content From Our Affiliates

Profile

MORE
Exscientia PLC is a United Kingdom-based artificial intelligence (AI)-driven precision medicine company. It is focused on discovering, designing and developing the possible drugs. It has developed the functional precision oncology platform to guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Its internal pipeline is focused on leveraging its...
David Nicholson Ph.D.
Non-Executive Independent Chairman of the Board
David Hallett Ph.D.
Interim Chief Executive Officer, Chief Scientific Officer
Ben Taylor
Chief Financial and Strategy Officer, Director
Garry Pairaudeau Ph.D.
Chief Technology Officer
Address
The Schrodinger Building
Oxford Science Park
Oxford
OX4 4GE
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
OABI
OmniAb Inc
4.67+0.07+1.52%
VERV
Verve Therapeutics Inc
6.41+0.26+4.23%
APLT
Applied Therapeutics Inc
4.76+0.23+5.08%
CCCC
C4 Therapeutics Inc
6.74+0.31+4.82%
ABSI
Absci Corp
5.08+0.10+2.01%